CPT2 and breast cancer: The apoptosis produced by a thiopheno‐pyrimidine‐based FASN inhibitor (Fasnall) in breast cancer cell lines was a result of malonyl‐CoA accumulation, which is known to decrease carnitine palmitoyl transferase‐1 (CPT‐1) activity but had no effect on FASN expression [93].